165 related articles for article (PubMed ID: 35596661)
1. Clinical characteristics, prognostic factors, and survival trends in esophageal neuroendocrine carcinomas: A population-based study.
Chen C; Hu H; Zheng Z; Yang Y; Chen W; Qiao X; Li P; Zhang S
Cancer Med; 2022 Dec; 11(24):4935-4945. PubMed ID: 35596661
[TBL] [Abstract][Full Text] [Related]
2. Comparison of clinicopathological features and survival analysis between esophageal neuroendocrine carcinoma and esophageal squamous cell carcinoma based on the SEER database, alongside nomogram analysis for esophageal neuroendocrine carcinoma.
Lin Z; Chen YY; Liu CH; Panzuto F; Ramirez RA; Lang M; Kim H; Ding ZY
J Gastrointest Oncol; 2023 Dec; 14(6):2309-2323. PubMed ID: 38196527
[TBL] [Abstract][Full Text] [Related]
3. Nationwide survey of neuroendocrine carcinoma of the esophagus: a multicenter study conducted among institutions accredited by the Japan Esophageal Society.
Sohda M; Kuwano H; Saeki H; Miyazaki T; Sakai M; Kakeji Y; Toh Y; Doki Y; Matsubara H
J Gastroenterol; 2021 Apr; 56(4):350-359. PubMed ID: 33582864
[TBL] [Abstract][Full Text] [Related]
4. Incidence, treatment, and survival analysis in esophageal neuroendocrine carcinoma population.
Li Z; Hu J; Chen P; Zeng Z
Transl Cancer Res; 2020 Jul; 9(7):4317-4329. PubMed ID: 35117798
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathological features, treatment modalities, and prognosis of esophageal neuroendocrine carcinoma: A single-center retrospective study.
Zhang Y; Liao JT; Lin Y; Liu C; Wu ZH; Yu B; Sun S; Yu H; Hui XH; Wu XH; Zhao XM; Wang HJ; Zheng Q; Li Y; Hu ZH; Wang JL
J Dig Dis; 2023; 24(8-9):472-479. PubMed ID: 37596865
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological analysis of 67 cases of esophageal neuroendocrine carcinoma and the effect of postoperative adjuvant therapy on prognosis.
Liu S; Ge X; Gao Z; Zhou Q; Shi Y; Jiang W; Yang M; Sun X
Medicine (Baltimore); 2021 Oct; 100(43):e27302. PubMed ID: 34713821
[TBL] [Abstract][Full Text] [Related]
7. Esophageal Neuroendocrine Carcinoma With Pathological Complete Response After Neoadjuvant Chemotherapy Followed by Robot-assisted Surgery: A Case Report.
Hirano K; Hirohata R; Hamai Y; Yamaguchi S; Emi M; Yoshikawa T; Ohsawa M; Okada M
Anticancer Res; 2023 Jul; 43(7):3289-3293. PubMed ID: 37351985
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic Immunostaining and Tumor Markers Predict the Prognosis of Esophageal Neuroendocrine Cell Carcinoma Patients.
Sohda M; Saeki H; Kuwano H; Miyazaki T; Yokobori T; Sano A; Sakai M; Kakeji Y; Toh Y; Doki Y; Matsubara H
Ann Surg Oncol; 2021 Nov; 28(12):7983-7989. PubMed ID: 33843025
[TBL] [Abstract][Full Text] [Related]
9. Laryngeal Neuroendocrine Carcinoma: A Population-Based Analysis of Incidence and Survival.
Ghosh R; Dutta R; Dubal PM; Park RC; Baredes S; Eloy JA
Otolaryngol Head Neck Surg; 2015 Dec; 153(6):966-72. PubMed ID: 26183520
[TBL] [Abstract][Full Text] [Related]
10. THE PROGNOSIS OF THE DIFFERENT ESOPHAGEAL NEUROENDOCRINE CARCINOMA SUBTYPES: A POPULATION-BASED STUDY.
Tustumi F; Marques SSB; Barros EF; Henriques AC; Waisberg J; Dias AR
Arq Gastroenterol; 2022; 59(1):53-57. PubMed ID: 35442337
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological, metastatic and prognostic features of stage IV esophageal adenocarcinoma versus squamous cell carcinoma: a SEER database analysis.
Pan L; Zhang Y; Gao Y; Qiu J
Chin Clin Oncol; 2024 Feb; 13(1):2. PubMed ID: 38372056
[TBL] [Abstract][Full Text] [Related]
12. The clinicopathologic features and prognosis of esophageal neuroendocrine carcinomas: a single-center study of 53 resection cases.
Ye L; Lu H; Wu L; Zhang L; Shi H; Wu HM; Tu P; Li M; Wang FY
BMC Cancer; 2019 Dec; 19(1):1234. PubMed ID: 31852479
[TBL] [Abstract][Full Text] [Related]
13. Late-stage esophageal neuroendocrine carcinoma in a patient treated with tislelizumab combined with anlotinib: a case report.
Zhang Y; Liu X; Liang H; Liu W; Wang H; Li T
J Int Med Res; 2023 Jul; 51(7):3000605231187942. PubMed ID: 37498227
[TBL] [Abstract][Full Text] [Related]
14. [Prognostic analysis of cervical lymph node metastasis in patients with thoracic esophageal squamous cell carcinoma].
Chen J; Zhu K; Zheng X; Chen M; Lin Y; Pan C; Pan J
Zhonghua Zhong Liu Za Zhi; 2014 Aug; 36(8):612-6. PubMed ID: 25430029
[TBL] [Abstract][Full Text] [Related]
15. Relationship between T stage and survival in distantly metastatic esophageal cancer: A STROBE-compliant study.
Deng J; Chu X; Ren Z; Wang B
Medicine (Baltimore); 2020 May; 99(19):e20064. PubMed ID: 32384472
[TBL] [Abstract][Full Text] [Related]
16. Population-based analysis of esophageal large cell neuroendocrine carcinoma between 2004 and 2015.
Yuan G; Zhan C; Zhu D; Xie H; Wei T; Lu T; Yang Y; Zhu Y; Wang Q
J Thorac Dis; 2019 Dec; 11(12):5480-5488. PubMed ID: 32030267
[TBL] [Abstract][Full Text] [Related]
17. [Patterns of recurrence in patients with stage pT3N0M0 thoracic esophageal squamous cell carcinoma after two-field esophagectomy].
Wang Y; Wang L; Yang Q; Li J; He M; Yao J; Qi Z; Li B; Qiao X
Zhonghua Zhong Liu Za Zhi; 2016 Jan; 38(1):48-54. PubMed ID: 26796807
[TBL] [Abstract][Full Text] [Related]
18. [Associated factors of postoperative relapse and metastasis in pT1bN0M0-pT4aN0M0 thoracic esophageal squamous cell carcinoma].
Pan W; Xiang Y; Gu Z; Ji C; Mao T; Fang W
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Sep; 20(9):1045-1049. PubMed ID: 28900998
[TBL] [Abstract][Full Text] [Related]
19. [Clinical and prognostic features of the patients with esophageal squamous cell carcinomas as a first primary malignancy].
Wen Z; Zhang YQ; Wu R; Peng XM; Chen B; Leng AM
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2021 Jul; 37(4):407-414. PubMed ID: 34374262
[No Abstract] [Full Text] [Related]
20. The different prognostic factors between metastatic and nonmetastatic disease of esophageal neuroendocrine carcinoma.
Zhong L; Pan Y; Han S; Qi Q; Liao H; Jiang Y; Shen J
Indian J Cancer; 2023 Oct; 60(4):512-520. PubMed ID: 38206083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
